The psychiatry sweep returned two routine drug items and nothing from enforcement. The one worth naming is a supplemental approval on 10 August for generic olanzapine from Dr Reddy's Laboratories under ANDA 076133. This is an ordinary manufacturing action, not a safety communication.
It is worth a paragraph only because of what today's weight meta-analysis says about the drug. Olanzapine is among the most obesogenic antipsychotics in wide use, and it is also among the cheapest — which is precisely why it is prescribed heavily in resource-limited settings, and why expanding generic supply increases exposure to a metabolic risk that is then rarely monitored.
The actionable step is not about the approval. It is that a patient started on olanzapine needs baseline weight, waist circumference, fasting glucose or HbA1c, and a lipid profile, with repeat measurement at three months and then annually. That schedule is widely recommended and inconsistently done, and the gap is the reason antipsychotic-induced metabolic disease is usually detected late.
What the sweep does not see is worth stating. It covers FDA drug approvals and enforcement actions only. American Psychiatric Association, World Psychiatric Association, NICE and Indian Psychiatric Society guidance published as web documents does not appear, nor do CDSCO notices. On most days the guidance that would change psychiatric practice is in one of those.
- Record baseline weight, waist, fasting glucose or HbA1c and lipids before starting any antipsychotic, olanzapine especially
- Repeat the metabolic panel at three months and then at least annually
- Where olanzapine is chosen for cost or efficacy, plan the metabolic monitoring at the same consultation
- Consider a less obesogenic agent first where the psychiatric indication allows
- Note the coverage gap: APA, WPA, NICE, Indian Psychiatric Society and CDSCO guidance do not reach this feed
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.
Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for psychiatry, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free